New Generic Launch – Latuda (Lurasidone HCl)

Author: APCI Staff/Tuesday, February 21, 2023/Categories: Generics and Vendor Contracting, Generic Bulletins

Amneal and Accord launched a new-to-market generic: Latuda (Lurasidone HCl). Amneal is approved for OS A and Accord will be added to an AC slot, effective February 21, 2023. The estimated U.S. brand sales for Latuda (Lurasidone HCl) are $4,308M. ASAP Shipments will apply.

OneStop Items

Item # NDC: Description
AMNEAL:
2667004  65162087903 LURASIDONE HCL TB 20MG AMN 30
2667012 65162088003 LURASIDONE HCL TB 40MG AMN 30
2667020  65162008203 LURASIDONE HCL TB 60MG AMN 30
2667038 65162088103 LURASIDONE HCL TB 80MG AMN 30
2667046  65162088203 LURASIDONE HCL TB 120MG AMN 30
ACCORD:
2674323 16729034610 LURASIDONE HCL TB 20MG ACC 30
2674380 16729034710 LURASIDONE HCL TB 40MG ACC 30
2674406 16729034810 LURASIDONE HCL TB 60MG ACC 30
2674414 16729034910 LURASIDONE HCL TB 80MG ACC 30
2674422 16729035010 LURASIDONE HCL TB 120MG ACC 30
Tags:

Comments are only visible to subscribers.